HomeNews

News

Why Scientific Trials Don’t Need to Be Sufferers’ ‘Final Line of Protection’

Wendy Brooks advised CURE® that she feels “blessed” to be a part of a scientific trial evaluating the antibody-drug conjugate ABBV-706 in small...

Columvi Exhibits Excessive Response Charges and Security in R/R Mantle Cell Lymphoma

A standard aspect impact related to Columvi included cytokine launch syndrome, analysis confirmed.Amongst closely pre-treated sufferers with relapsed or refractory mantle cell lymphoma,...

How Do You Survive Most cancers Survivorship?

Jessica Bolz is a four-time most cancers survivor after diagnoses of Hodgkin lymphoma and breast most cancers. Make amends for Jessica's blogs right...

COVID-19 RNA Might Be Linked to Metastatic Most cancers Regression

When RNA from COVID-19 is launched into the bloodstream, it prompts a sure white blood cell, which turns into cancer-fighting cells, an knowledgeable...

Trial for Sufferers With Excessive-Threat MDS Misses Aim, Discontinues Research

A part 3 trial will likely be discontinued after two therapy teams confirmed comparable outcomes. The first finish level was not met in...

Hot Topics